The state of Kentucky currently has 74 active clinical trials seeking participants for Lung Cancer research studies. These trials are conducted in various cities, including Louisville, Lexington, Owensboro and Paducah.
Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
Recruiting
This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to grow. AMG 510, a targeted treatment against the KRAS G12C mutation, may help stop the growth of tumor cells.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/09/2022
Locations: Flaget Memorial Hospital, Bardstown, Kentucky +9 locations
Conditions: Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
Recruiting
The purpose of this study is to determine how beta-glucan affects the immune system in subjects with non-small cell lung cancer.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/05/2022
Locations: James Graham Brown Cancer Center, Louisville, Kentucky
Conditions: Non Small Cell Lung Cancer